Compare FDX & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDX | ELV |
|---|---|---|
| Founded | 1971 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.6B | 85.7B |
| IPO Year | 1997 | 2001 |
| Metric | FDX | ELV |
|---|---|---|
| Price | $315.78 | $416.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 19 |
| Target Price | $376.67 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 2.1M | 1.6M |
| Earning Date | 03-19-2026 | 04-22-2026 |
| Dividend Yield | 1.49% | ★ 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.91 | 8.00 |
| Revenue | $65,450,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $7.43 | N/A |
| Revenue Next Year | $4.96 | $3.07 |
| P/E Ratio | ★ $26.28 | $52.24 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $216.10 | $273.71 |
| 52 Week High | $413.87 | $427.19 |
| Indicator | FDX | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 60.47 |
| Support Level | $302.65 | $382.77 |
| Resistance Level | $318.83 | $426.98 |
| Average True Range (ATR) | 9.60 | 10.07 |
| MACD | 0.24 | 1.18 |
| Stochastic Oscillator | 19.57 | 72.91 |
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In fiscal 2025, the firm's Federal Express segment—which houses the core package delivery operations—made up 86% of total revenue, with 10% coming from FedEx Freight, its asset-based less-than-truckload shipping segment. The remainder came from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016, boosting its presence across Europe. TNT was previously the fourth-largest global parcel delivery provider.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.